drugset
drugset / Trial / NCT03082768

Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects

NCT03082768 ↗

Phase 0 Completed 6 enrolled Molecular NeuroImaging
NaSingle-groupOpen-labelOther

Summary

The overall goal of this protocol is to evaluate \[18F\]MNI-968 (aka PF-06730110) as a D1 receptor targeted radiopharmaceutical.

Timeline

Start
2017-03-03
Primary completion
2018-03-01
Completion
2018-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]MNI-968 Unknown — —

Indications

No indication recorded.